Diagnosis and treatment tachycardia-induced cardiomyopathy: case report
https://doi.org/10.35336/VA-2022-4-08
Abstract
The article highlights current issue of the etiology of cardiomyopathy resulting from persistent tachycardia. Clinical studies devoted to the diagnosis and treatment of tachycardia-induced cardiomyopathy and the criteria for its diagnosis are presented. The article presents a clinical case report of a 48-year-old patient who developed cardiomyopathy against the background of long-term persistent tachysystolic atrial fibrillation. After the restoration of the sinus rhythm against the background of optimal drug therapy, the clinical signs of cardiomyopathy regressed, the size of the heart chambers and the contractile function of the myocardium of the left ventricle of the heart returned to normal.
About the Authors
V. I. Steklov
«Central Military Clinical Hospital named after P.V. Mandryka», Ministry of Defense of Russia
Russian Federation
Russian Federation
Vladimir Steklov
Moscow, 8A Bolsyaha Olenya str.
M. B. Patsenko
Main Military Medical Directorate of the Russian Ministry of Defense
Russian Federation
Russian Federation
Moscow, 14 Znamenka str.
A. V. Demyanenko
«Central Military Clinical Hospital named after P.V. Mandryka», Ministry of Defense of Russia
Russian Federation
Russian Federation
Moscow, 8A Bolsyaha Olenya str.
M. V. Lipskaya
«Central Military Clinical Hospital named after P.V. Mandryka», Ministry of Defense of Russia
Russian Federation
Russian Federation
Moscow, 8A Bolsyaha Olenya str.
S. O. Lependin
«Central Military Clinical Hospital named after P.V. Mandryka», Ministry of Defense of Russia
Russian Federation
Russian Federation
Moscow, 8A Bolsyaha Olenya str.
F. G. Rzayev
City Clinic Hospital named after I.V.Davidovsky
Russian Federation
Russian Federation
Moscow, 11 Yauzkaya str.
References
1. Bockeria LA, Shengeliya LD. Changes in the heart associated with atrial fibrillation. Part I. Cardiopathy of atrial fibrillation: new dilemmas and old problems. An Arrhythmology. 2016;3(2): 138-47 (In Russ.) https://doi.org/10.15275/annaritmol.2016.3.2.
2. Hasdemir C, Ulucan C, Yavuzgil O, et al. Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiologic characteristics, and the predictors. J Cardiovasc Electrophysiol. 2011;22(6): 663-8. https://doi.org/10.1111/j.1540-8167.2010.01986.x.
3. Pizzale S, Lemery R, Green MS, et al. Frequency and predictors of tachycardia induced cardiomyopathy in patients with persistent atrial flutter. Can J Cardiol. 2009;25(8): 469-72. https://doi.org/10.1016/s0828-282x(09)70119-9.
4. Santhanakrishnan R, Wang N, Larson MG, et al. Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133(5): 484-92. https://doi.org/10.1161/01.CIRCULATIONAHA.115.018614.
5. Steklov VI, Morozov DA, Lependin SO, et al. Newly diagnosed atrial fibrillation: choice of tactics. IX Russian congress of arrhythmologists. Saint Petersburg-2021. Theses. 119-20. (In Russ.).
6. Gopinathannair R, Sullivan R, Olshansky B. Tachycardia-mediated cardiomyopathy: recognition and management. Curr Heart Fail Rep. 2009;6(4): 257-64. https://doi.org/10.1007/s11897-009-0035-3.
7. Mueller Karin AL, Heinzmann D, Klingel K, et al. Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy. J Am Coll Cardiol. 2017;69(17): 2160-72. https://doi.org/10.1016/j.jacc.2017.02.049.
8. Gossage AM, Hicks JB. On auricular fibrillation. QJM An International Journal of Medicine. 1913;6: 435-440.
9. Phillips E, Levine SA. Auricular fibrillation without other evidence of heart disease. Am J Med. 1949;7(4): 478-89. https://doi.org/10.1016/0002-9343(49)90397-6.
10. Whipple GH. Reversible congestive heart failure due to chronic rapid stimulation of the normal heart. In Proceedings of the New England Cardiovascular Society. 1962;20: 39-40.
11. Okada A, Nakajima I, Morita Y, et al. Diagnostic value of right ventricular dysfunction in tachycardia-induced cardiomyopathy using cardiac magnetic resonance imaging. Circ J. 2016;80: 2141-2148.
12. Elliott P. Defining Tachycardia-Induced Cardiomyopathy: Life in the fast lane. J Am Coll Cardiol. 2017;69: 2173-2174.
13. Medi C, Kalman JM, Haqqani H, et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol. 2009; 53(19): 1791-7. https://doi.org/10.1016/j.jacc.2009.02.014.
14. Redfield MM, Kay GN, Jenkins LS, et al. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc. 2000;75(8): 790-795. https://doi.org/10.4065/75.8.790.
15. Ardashev AV, Belenkov YuN, Matsiukevich MCh, et al. Atrial Fibrillation and Mortality: Prognostic Factors and Direction of Prevention. Kardiologiia. 2021;61(2): 91-98. (In Russ.) https://doi.org/10.18087/cardio.2021.2.n1348.
16. Brembilla-Perrot B, Ferreira JP, Manenti V, et al. Predictors and prognostic significance of tachycardiomyopathy: insights from a cohort of 1269 patients undergoing atrial flutter ablation. Eur J Heart Fail. 2016;18(4): 394-401. https://doi.org/10.1002/ejhf.482.
17. Lee GK, Klarich KW, Grogan M, et al. Premature ventricular contraction-induced cardiomyopathy: a treatable condition. Circ Arrhythm Electrophysiol. 2012;5(1): 229-36. https://doi.org/10.1161/CIRCEP.111.963348.
18. Yokokawa M, Good E, Crawford T, et al. Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes. Heart Rhythm. 2013;10(2): 172-5. https://doi.org/10.1016/j.hrthm.2012.10.011.
19. Watanabe H, Okamura K, Chinushi M, et al. Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy. Int Heart J. 2008;49(1): 39-47. https://doi.org/10.1536/ihj.49.39.
20. Nerheim P, Birger-Botkin S, et al. Heart failure and sudden death in patients with tachycardia induced cardiomyopathy and recurrent tachycardia. Circulation. 2004;110: 247-52. https://doi.org/10.1161/01.CIR.0000135472.28234.
21. Huizar JF, Ellenbogen KA, Tan AY, et al. Arrhythmia-Induced Cardiomyopathy. J Am Coll Cardiol. 2019;73(18): 2328-44. https://doi.org/10.1016/j.jacc.2019.02.045.
22. Donghua Z, Jian P, Zhongbo X, et al. Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia. J Interv Card Electrophysiol. 2013;36(1): 27-32. https://doi.org/10.1007/s10840-012-9727-9.
23. Brignole M, Pentimalli F, Palmisano P, et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. European Heart Journal. 2021; ehab569. https://doi.org/10.1093/eurheartj/ehab569.
24. Brignole M, Pokushalov E, Pentimalli F, et al. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. European Heart Journal. 2018;39: 3999-4008. https://doi.org/10.1093/eurheartj/ehy555.
25. Gupta S, Figueredo VM. Tachycardia mediated cardiomyopathy: pathophysiology, mechanisms, clinical features and management. Int J Cardiol. 2014;172(1): 40-6. https://doi.org/10.1016/j.ijcard.2013.12.180.
26. Jeong YH, Choi KJ, Song J-M, et al. Diagnostic Approach and Treatment Strategy in Tachycardia-induced Cardiomyopathy. Clin Cardiol. 2008;31(4): 172-8. https://doi.org/10.1002/clc.20161.
27. Stukalova OV, Gupalo EM, Chumachenko PV, et al. The value of cardiovascular magnetic resonance in myocarditis with different clinical presentation. Ter Arkh. 2019; 91(4): 28-36. (In Russ.) https://doi.org/10.26442/00403660.2019.04.000078.
28. Prabhu S, Taylor AJ, Costello BT, et al. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: The CAMERA-MRI study. J Am Coll Cardiol. 2017;70(16): 1949-61. https://doi.org/10.1016/j.jacc.2017.08.041.
29. Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control Therapy in Patients With Atrial Fibrillation. N Engl J Med. 2020;383: 1305-1316. https://doi.org/10.1056/NEJMoa2019422.
Review
For citations:
Steklov V.I., Patsenko M.B., Demyanenko A.V., Lipskaya M.V., Lependin S.O., Rzayev F.G. Diagnosis and treatment tachycardia-induced cardiomyopathy: case report. Journal of Arrhythmology. 2022;29(4):53-60. https://doi.org/10.35336/VA-2022-4-08
Views:
481
Email this article 